Bhargav Dhirajlal Kotadia – MD & CEO - Sahajanand Medical Technologies of Sahajanand Medical Technologies
View Detailed Executive Profile →Professional Overview
- Bhargav Kotadia has been appointed as the Managing Director and Chief Executive Officer of Sahajanand Medical Technologies (SMT), a significant leadership role in a prominent medical devices company.
- The appointment as CEO took effect on April 1, 2025, marking a new chapter in Kotadia's career and the strategic direction of SMT.
- Prior to this role, Kotadia was recognized for his contributions to the healthcare and biotech sectors, showcasing a strong background in leadership and innovation.
- Under Kotadia's leadership, SMT aims to enhance its market presence and drive advancements in medical technology, particularly in the field of cardiovascular devices.
- Kotadia's appointment was supported by Samara Capital, indicating a strategic partnership aimed at fostering growth and innovation within SMT.
- As CEO, Kotadia is expected to leverage his expertise to navigate the challenges of the medical devices industry, focusing on quality and patient outcomes.
- Bhargav Kotadia's leadership style emphasizes collaboration and strategic decision-making, which are crucial for steering SMT towards its long-term goals.
- With a staff count of approximately 940, Kotadia's role involves overseeing a significant workforce dedicated to developing and manufacturing medical devices.
- Kotadia's vision for SMT includes expanding its product offerings and enhancing research and development efforts to stay competitive in the medical technology landscape.
- His leadership is anticipated to foster a culture of innovation within SMT, encouraging teams to explore new technologies and solutions in healthcare.
- Bhargav Kotadia's strategic decisions are likely to focus on sustainability and ethical practices in the production and distribution of medical devices.
- As a member of the Board of Directors at SMT, Kotadia plays a crucial role in shaping the company's governance and strategic initiatives.
- Kotadia's appointment is seen as a pivotal moment for SMT, aligning the company with industry trends and enhancing its competitive edge.
- His leadership is expected to drive SMT's mission of improving patient care through innovative medical solutions, reflecting a commitment to healthcare excellence.
- Bhargav Kotadia's career trajectory exemplifies a dedication to advancing the medical technology field, making significant contributions to healthcare innovation.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Sahajanand Medical Technologies | Managing Director | Jan 2013 – Apr 2025 |
| SAHAJANAND MEDICAL TECHNOLOGIES LIMITED | Director | 28-Sep-2013 – 01-Dec-2017 |
| SAHAJANAND TECHNOLOGIES PRIVATE LIMITED | Director | 28-Sep-2013 – 19-Jul-2023 |
| SAHAJANAND LIFE SCIENCES PRIVATE LIMITED. | Director | 27-Sep-2013 – 01-Aug-2023 |
| VASCULAR CONCEPTS LIMITED | Additional Director | 22-May-2020 – 31-Dec-2020 |
| SAHAJANAND LIFE SCIENCES PRIVATE LIMITED. | Additional Director | 06-May-2013 – 27-Sep-2013 |
| SAHAJANAND MEDICAL TECHNOLOGIES LIMITED | Additional Director | 06-May-2013 – 28-Sep-2013 |
| SAHAJANAND TECHNOLOGIES PRIVATE LIMITED | Additional Director | 06-May-2013 – 28-Sep-2013 |
| SAHAJANAND MEDICAL TECHNOLOGIES LIMITED | Managing Director | 01-Dec-2017 – 30-Nov-2022 |
| Sahajanand Medical Technologies | MD & CEO | Apr 2025 – Present |
| VASCULAR CONCEPTS LIMITED | Director | 31-Dec-2020 – Present |
| SMT CARDIOVASCULAR PRIVATE LIMITED | Director | 16-Nov-2019 – Present |
| SAHAJANAND MEDICAL TECHNOLOGIES LIMITED | Managing Director | 01-Dec-2017 – Present |
Current Appointments
| CIN/LLP | Company | Designation | Date |
|---|---|---|---|
| U33119GJ1992PLC141664 | VASCULAR CONCEPTS LIMITED | Director | 31-Dec-2020 |
| U33119GJ2001PLC040121 | SAHAJANAND MEDICAL TECHNOLOGIES LIMITED | Managing Director | 01-Dec-2017 |
| U33302GJ2019PTC110835 | SMT CARDIOVASCULAR PRIVATE LIMITED | Director | 16-Nov-2019 |
Previous Appointments
| CIN/LLP | Company | Designation | Period |
|---|---|---|---|
| U24231GJ2001PTC039726 | SAHAJANAND LIFE SCIENCES PRIVATE LIMITED. | Additional Director | 06-May-2013 – 27-Sep-2013 |
| U24231GJ2001PTC039726 | SAHAJANAND LIFE SCIENCES PRIVATE LIMITED. | Director | 27-Sep-2013 – 01-Aug-2023 |
| U33119GJ1992PLC141664 | VASCULAR CONCEPTS LIMITED | Additional Director | 22-May-2020 – 31-Dec-2020 |
| U33119GJ2001PLC040121 | SAHAJANAND MEDICAL TECHNOLOGIES LIMITED | Additional Director | 06-May-2013 – 28-Sep-2013 |
| U33119GJ2001PLC040121 | SAHAJANAND MEDICAL TECHNOLOGIES LIMITED | Director | 28-Sep-2013 – 01-Dec-2017 |
| U33119GJ2001PLC040121 | SAHAJANAND MEDICAL TECHNOLOGIES LIMITED | Managing Director | 01-Dec-2017 – 30-Nov-2022 |
| U72900GJ1993PTC019133 | SAHAJANAND TECHNOLOGIES PRIVATE LIMITED | Additional Director | 06-May-2013 – 28-Sep-2013 |
| U72900GJ1993PTC019133 | SAHAJANAND TECHNOLOGIES PRIVATE LIMITED | Director | 28-Sep-2013 – 19-Jul-2023 |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Sahajanand Medical Technologies corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Bhargav Dhirajlal Kotadia's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Sahajanand Medical Technologies's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)